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 A generalized design-comparable effect size modeling and estimation for 
multiple baseline designs across individuals has been proposed and evaluated by 
Restricted Maximum Likelihood method in a hierarchical linear model using R. This 
report evaluates the exact approach of the modeling and estimation by SAS.  Three 
models (MB3, MB4 and MB5) with same fixed effects and different random effects are 
estimated by PROC MIXED procedure with REML method. The unadjusted size and 
adjusted effect size are then calculated by matrix operation package PROC IML. The 
estimations for the fixed effects of the three models are similar to each other and to that 
of R. The variance components estimated by the two software packages are fairly close 
for  MB3 and MB4,  but the results are different for  MB5 which exhibits boundary 
conditions for variance-covariance matrix. This result suggests that the nlme library in R 
works differently than the PROC MIXED REML method in SAS under extreme 
conditions.      
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 As a way of quantifying the difference between two groups, effect size is a 
common statistical evaluation of the strength of relationships between the outcome and 
treatment in meta-analysis. There are many different effect sizes for use with different 
types of outcome data and experimental design. In simple experiment design, Cohen’s d 
or the standardized mean difference is widely used as the effect size (1).  The basic 
formula to calculate the effect size has two parts. The numerator is the difference 
between the mean of the measurement experiment group and control group. The 
denominator is the standard deviation of the scores of the control group. The sign (plus or 
minus) indicates the direction of the relation while the value indicates the strength. Thus, 
an effect size near zero means on average, i.e., there is no difference between the control 
and experiment group; in other words, the treatment or intervention in the experiment has 
no effect. A positive effect size means that the experiment group performs better than the 
control group. A negative value means that the control group performs better than the 
experiment group. In both cases the larger the  absolute value of the effect size, the more 
effective the treatment.  Some researchers have agreed to an arbitrary criterion that an 
effect size less than 0.20 indicates weak treatment, greater than 0.8 as strong treatments 
and between 0.2 and 0.8 as moderate treatment (2). Although this simple categorization 
can provide some guidance, evaluation of the effectiveness of a treatment should be 
considered case by case (3).  
While d-type effect size is straightforward for simple studies, in practice  studies 
often involve more complicated designs, for which estimation of the effect size is more 
challenging. Single case designs (SCDs) are a class of research studies, which are 
becoming popular in clinical studies and other applied areas such as  psychology, 
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counseling and education. Unlike true experiments where researchers randomly assigns 
participants to a control and treatment group, in SCDs each participant serves as both.  
The outcome variable will be repeated and systematically measured before and after 
intervention or treatment for each participant over time. Two important phases are 
involved including baseline phase and intervention phase. There are several important 
types of SCDs such as ABAB design, alternating treatment design, multiple baseline 
design, withdrawal design and reversal design, among which multiple baseline design is 
the most widely used method. Shadish and Sullivan (4) have compiled a master list of 
SCDs from 21 journals published in 2008 and found 809 single-case designs appearing in 
113 studies in a variety of fields in psychology and education. Among those 54.3% of the 
cases used multiple baseline design and 25.1% used combination of multiple baseline 
design and other designs. In multiple baseline design the treatment or intervention is 
applied to each participant at a different time and the outcome variable is measured 
before and after treatment continuously until stabilized. 
 The traditional method to evaluate the effect of the treatment of SCDs is to draw 
the line graph of the outcome over time points and visually inspect the change or slope of 
the outcome (5). Kazdin (6) proposed that four primary criterion should be focused when 
inspecting the data visually. They are change in mean, change in level, change in trend 
and latency to change of the outcome over the transition of conditions.  Researches are 
also looking for inferential statistical methods  to detect and evaluate  the treatment effect  
systematically and quantitatively. 
The challenge of using statistical analysis is how to define and estimate the effect 
of the treatment in SCDs. The experimental design of the treatment or the measurement 
instrument  of outcome could be different across studies. Though the conclusion of the 
treatment effect should not vary because of the study designs. Thus a design-comparable 
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effect size is desired to measure the effect of treatment on same metric across studies.  
Recently Pustejovsky (7) has successfully constructed design-comparable effect size for 
multiple baseline design using Hierarchical Linear Modeling (HLM).  The multiple 
baseline design involves repeated measurements of the outcomes over time and 
controlled introduction of the treatment at different time for different individuals. The 
variance components include within-individual variation across treatment occasions and 
variation across individuals. The key point of the design is that the model is general 
enough to incorporate single case design and between-subjects randomization. Then an 
effect size is constructed comparably to Cohen’s d-type effect size.  Unlike previous 
studies with strong assumption that the baseline before treatment is stable and the 
outcome after the treatment is stable (8), Pustejovsky’s work has more generalized 
condition  by allowing trends in both baseline and after treatment phase, which may 
result in broader application. 
 This report will first introduce the construction of Pustejovsky’s effect size by 
hierarchical linear model (HLM) and estimation the parameter by restricted maximum 
likelihood estimation (REML) method in R. Three variations of the model will be 
discussed and effect size will be estimated by REML method in SAS. The results by two 
different software packages will be compared and analyzed.   
STATISTICAL MODEL 
Pustejovsky has constructed a two-level model where level one describes a 
causally interpretable regression model for the i
th
 individual and level two describes the 
variation of the regression coefficients across cases. Causally interpretable means that the 
model describes not only the observed outcome data but also potential outcomes under 
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variations in how treatment is assigned. A general function of level one is written as 
following: 
Yij(Ti) = β0i + β1i 1( j > Ti ) +  β2i ( j - C ) + β3i (( j - Ti ) x 1( j > Ti )) +       (1) 
Here outcome Yij is a function of treatment assignment time Ti for the     individual  at 
measurement time j. There are totally m individuals and N measurement occasions. For 
case i, Ti measurements are made during the baseline phase where 0 ≤ Ti ≤ N. Then the 
case receives treatment and N - Ti more measurements are made after the treatment. 1( j > 
Ti ) is an indicator variable that equals to 0 before the treatment and 1 after receiving the 
treatment. We assume that the measurement occasions are equally spaced and centered at 
the constant C.  For each individual i, the treatment may be introduced at different time, 
the baseline phase may have different time points, and after treatment phase may also 
have different time points.   
The interpretation of the coefficients is described as follows.  
β0i : Average level of outcome at time j = C without treatment for case i 
β1i : Immediate change of the outcome due to the introduction of treatment for case i 
β2i : Linear change of the outcome per measurement occasion for case i 
β3i : Additional change of the outcome per measurement occasion with the treatment for 
case i 
Simply regarding the error terms     as independent is not plausible since the 
measurements of each case are taken over time (8). Here an AR(1) model is used, where  
the errors are assumed to be auto-correlated and to follow a stationary, first-order auto-
regressive process. The errors have expectation zero, variance σ
2
, and first order 




within cases. All errors are assumed to be 
independent across cases where Cov(    ,    ) = 0 if h ≠ i. 
The d-type design-comparable effect size is given by: 
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 (   ( ))  (   ( ))
√   (   ( ))
                                                (2) 
where effect size equals the difference between the average outcome if treatment is 
introduced at time A,    ( ), and if treatment is never introduced,    ( ), divided by the 
standard deviation of the outcome without treatment where all outcomes are measured at 
a fixed time B. Pustejovsky has specified five models with different group-level 
assumptions about the variation across cases in his study. Each model includes one 
varying component or a combination of several components including the intercept, 
treatment, time trend, and interaction between time trend and treatment. By allowing 
more variations in the model, more practical situations can be explained. Pustejovsky has 
estimated the effect size by statistical software package R for these models. In this report, 
a similar estimation is performed using SAS for 3 of the 5 models (MB3, MB4, and 
MB5), summarized as follows. 
Model MB3: Varying intercepts, fixed treatment effect, fixed trends: 
β0i = γ00 + η0i, β1i = γ10, β2i = γ20, β3i = γ30,     η0i ~ N(0,   
 )      (3) 
 Here β0i is the intercept, β1i is the treatment effect, γ00 can be interpreted as the 
average level of the outcome across individuals in the absence of the treatment, and γ10 is 
the immediate change in the outcome after intervention of treatment, γ20 is the change in 
the outcome per measurement unit in the absence of treatment, γ30 and η0i are the 
additional change in the outcome per measurement unit when treatment is introduced. 
The slope β2i is for the time trend and β3i is for the time by treatment interaction. All of 
γ10, γ20 and γ30 are constant across individuals. 
Applying conditions in (3) to equation (1) we find: 
E(YiB(N)) = γ00 + γ20 (B-C), 
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E(YiB(A)) = γ00 + γ10+γ20 (B-C) + γ30 (B-A), 
Var (Y1B(N) = Var (η0i +    ) = (  
  + σ
2
),  
and effect size 
 
    
         (   )
√  
    
                                                                                (4) 
Here difference (B-A) is the length of time held constant between treatment introduction 
and measurement, which does not depend on the choice of B because the variance is 
constant across measurement occasions, regardless of the pattern of treatment 
assignments. 
Model MB4: Varying intercepts, fixed treatment effect, varying trends: 
β0i = γ00 + η0i, β1i = γ10, β2i = γ20 + η2i, β3i = γ30,                                    (5) 
Here γ00 is the average level of outcome across individuals without treatment and η0i is 
the variance of the outcome for case i ,   γ10 and γ30 are the same as MB3, and γ20 is not 
constant as in MB3. In addition, (η0i, η2i) is multi-variate normally distributed, with 
mean (0, 0) and covariance matrix 
T=[
  
    
     
 ]                                     (6) 
 
Applying conditions in (5) to equation (1) we find: 
E(YiB(N)) = γ00 + γ20 (B-C), 
E(YiB(A)) = γ00 + γ10+γ20 (B-C) + γ30 (B-A), 
Var (Y1B(N) = Var (η0i + η2i (B-C) + òiB) =   
  + (B-C)
2  






    
         (   )
√  
  (   )   
    (   )      
                                                                (7) 
The effect size in (7) depends on the choice of both A and B. A simpler expression can be 
derived by centering at time C = B so that Var Y1B(N) is reduced to just (  
  + σ
2
) and 
effect size becomes the same as in MB3. The difference (B-A) is the length of time held 
constant between treatment introduction and measurement. Unlike MB3, the difference 
(B-A)  depends on the choice of B through the choice of centering point C . 
Model MB5: Varying intercepts, varying trends, varying treatment-by-time 
interaction: 
β0i = γ00 + η0i, β1i = γ10, β2i = γ20 + η2i, β3i = γ30 + η3i,                         (8) 
where (η0i, η2i, η3i) is multi-variate normally distributed, with mean (0, 0, 0) and 
covariance matrix 
    T=[
  
       
     
    
        
 
]                                                                (9) 
In this model, in the absence of treatment, cases vary in their average levels of the 
outcome and slope of change over time. The treatment also has variable effects by 
influencing the interaction term. Applying conditions in (8) to equation (1) we find the 
effect size is the same as equation (7). 
EFFECT SIZE ESTIMATION 
 In the above three HLM models, we can denote the (p x 1) vectors of fixed effects 
by   (       (   ) )
  and the (r x 1) vectors of the variance components by   
(  
        ) .  Effect size can then be simply expressed as a matrix operation: 
 
     
   
√   
                                                                             (10)  
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where p is the number of fixed effects and r is the number of all variance components 
including auto-correlation coefficient  , within-case variance    and random effect 
covariance  . For example, in MB3, take γ = (γ00, γ10, γ20,γ30 )
T
, P = (0, 1, 0, (B-A))
T
, 
take   (  
      ) , R = (1, 0,1)T, the effect size calculated by equation (10) is the 
same as in equation (4). 
 
The RML method then can be applied by estimating  ̂  ̂ and  ̂  . Based on the 
theorem given in Hedges (7), the distribution of  ̂   can be approximated by a constant k 
times a non-central t distribution with v degrees of freedom: 
 
   √
   ( ̂) 
   ̂
                                                                                  (11) 
 
  
 (   ̂) 
   ( ̂) 
                                                                                                 (12) 
An adjusted effect size is given by 
                     ( )   ̂                                                                             (13) 
where 
     ( )      (    )                       (14) 
The variance of     is approximately  
 
   (   )   ( )
  
   
   
  ̂  
 (
 
   
 
 
 ( ) 
)                                (15) 
Pustejovsky has implemented the RML estimation using the nlme package in R to 
estimate constant k and degree of freedom v to calculate the modified effect size. This 
report will use the Proc Mixed with REML method in SAS 9.2 to implement the 
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hierarchical linear models (MB3, MB4 and MB5) and calculate the effect size by matrix 





   
Implementation of the Methods by SAS 
SAS PROC MIXED 
Mixed procedure in SAS can be used to fit a variety of data and make statistical 
inference. Unlike the Generalized Linear Model (GLM) procedure for the standard linear 
model, the data in Mixed model are permitted to have correlations and non-constant 
variability; thus variance and covariance of the data can be modeled. There are three 
primary assumptions underlying the analysis by Proc Mixed. The first one is that the data 
are normally distributed (Gaussian). The second is that the means of the outcome are 
linear to a set of parameters noted as fixed effects. The third assumption is that the 
variance and covariance of the data are in terms of a different set of parameters noted as 
covariance parameters. The fixed effects parameters are associated with known 
explanatory variables which are the same as in traditional linear models. The unknown 
random effects provide additional variability to the data. The variances of the random 
effects parameters become the covariance parameter of the structure. The mixed 
procedures are widely used in the following two typical scenarios: 
First one is called nested study. The experimental units can be grouped into 
clusters and the data from a common cluster are correlated. For example, if students are 
the experiment unit, they can be grouped into classes, which in turn can be grouped into 
schools and then districts. Each level of this hierarchy can introduce an additional 
variability and correlation in the HLM model. 
The second one is called longitudinal study. Repeated measurements are taken on 
the same experimental unit over time. The measurements are correlated or exhibit 
variability.  This model is widely used in pharmaceutical clinical study, psychology and 
social science. Single case design study or multiple baseline study also conducts repeated 
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measurements over time for each individual which can be viewed as a special case of 
longitudinal study. Therefore the mixed procedure is used in this study.   
Proc Mixed fits the structure using method of restricted maximum likelihood 
(REML). It constructs an objective function associated with REML and maximizes it 
over all unknown parameters using ridge-stabilized Newton-Raphson (NR) algorithm (9). 
The advantage of NR algorithm over Expectation-Maximum (EM) has been presented in 
a previous study (10). The complicated mathematics of the estimation procedure is not 
discussed in this section. 
SUMMARY OF SCHUTTE DATA 
Schutta, Malouff, and Brown (11) conducted a study to evaluate adult’s prolonged 
fatigue problem by emotion-focused therapy using a multiple baseline across individuals.  
Before the treatment, cases were measured weekly, some for 2 weeks, some for 5 weeks 
and some for 8 weeks. Then treatments were applied. Cases were measured weekly again. 
The total length of the measurement is different for cases and it ranged from 1 to 7 
weeks. The longest case was 8 weeks of baseline and 7 weeks after treatment with total 
15 time points. The shortest case was 5 weeks of baseline and 1 week after treatment with 
total 6 time points. The fatigue measurement was a self-reported scale from 1 to 63. A 
total of 12 cases and 136 time points will be evaluated in this report. 
APPLICATIONS 
Previously Pustejovsky has used nlme package in R to estimate the effect size of 
different models. This report will replicate the calculation with Proc MIXED /REML 
method and Proc IML package in SAS.  I choose the three models (MB3, MB4 and MB5) 
described above to study the Schutte data and to estimate the effect size. The models 
differ only in whether the case-level regression specification are assumed to be constant 
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or allowed to vary. The model has three fixed factors including time trend, treatment and 
the interaction between time trend and treatment. The effect size parameter depends on 
the choice of time-points A and B for describing the hypothetical between-subjects 
design. For all these three models I use A=2, B=9 and C=9. By A=2, the treatment would 
be applied after the second measurement occasion in a hypothetical experiment. By B=9, 
the effect size measures the effect of B-A=7 weeks of the treatment, which is the 
maximum length recorded in the data. By C=9, I simplify the calculation by centering the 
weekly trend at 9 weeks. Therefore the case-level interpretation is corresponding to the 
average level of the outcome after 9 weeks without treatment.  
   Next I present the SAS codes for all three models and discuss the results in 
comparison with the results from R, as calculated by Pustejovsky.  
MB3 Code and Results 
Model 3 has varying intercept, fixed treatment effect, fixed trends and fixed 
interaction as in equation (3).   
β0i = γ00 + η0i, β1i = γ10, β2i = γ20, β3i = γ30,     η0i ~ N(0,   
 )  (3) The SAS code 
is illustrated and explained in three parts. Figure 1 is for data input, Figure 2 is modeling 
by PROC MIXED and output data reference, and Figure 3 is matrix operation by PROC 











       Figure 1: SAS code for MB3, part 1: Data input. 
The first part of the code is to get the raw data Schutte.csv into SAS and create 
SAS data set schutte with multiple variables specified in the INPUT statement.  The raw 
data is saved in the directory of 'U:\My Documents\My SAS Files\9.2\Effect_Size'. The 
first 15 observations are checked to see if the data are read correctly. After that the 











Figure 2: SAS code for MB3, part 2: Proc Mixed modeling 
ODS TRACE ON; 
 ODS OUTPUT   
  CovParms=w1 (keep=covparm estimate)  
  asycov=w2 (drop=row)   
  SolutionF=w3 (keep= effect estimate)  
  covb=w4 (drop =row);   
   
PROC mixed DATA=schutte METHOD=REML noclprint asycov 
covtest; 
 CLASS case; 
 MODEL Fatigue = Trt Week Trt_Week /SOLUTION covb; 
 REPEATED /SUB=case TYPE = ar(1); 
 RANDOM intercept  / SUB= case TYPE=un; 
RUN; 
ODS TRACE OFF; 
 
 
OPTIONS formdlim='_' ls=100; 
 
FILENAME io 'U:\My Documents\My SAS Files\9.2\Effect_Size'; 
  
DATA schutte; 
INFILE io(Schutte.csv) dlm='2C0D'x dsd missover lrecl=10000 
firstobs=2; 
 
INPUT Num case Week Fatigue Trt CaseID Treatment$ Constant 
Trt_Week; 
  
PROC PRINT DATA=schutte (obs=15); RUN;   
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Part 2 of the code is the main body of the modeling with estimation of all the 
fixed and random effects. The pair of ODS TRACE ON and OFF statement help to track 
the table names from the output in the log file of SAS.  ODS output will allow the direct 
reference and modification of the output tables and assign to new dataset for future 
calculation. The KEEP and DROP option can specify the selection of certain columns in 
the data set. In the PROC MIXED statement we tell SAS to use data set Schutte created 
in part 1 as input, use method REML as estimation method, print out standard deviation 
of estimated parameter by option covtest, and display the covariance matrix of parameter 
estimates by option asycov. The CLASS statement tells SAS to treat case as a categorical 
or classification variable.   The MODEL statement together with options is the core part 
of the code. It specifies that Fatigue is the outcome variable, three independent variables 
Trt, Week, and the interaction term Trt_Week are the three fixed effects. The option 
SOLUTION displays the parameter estimate in the output solutionF table according to 
the ODS TRACE line. The option covb displays the covariance matrix of the fixed effect 
parameter estimate in the output covb table. REPEATED statement estimates the 
variance-covariance matrix of the random residuals    , which can be viewed as the 
within-subject variance. The TYPE option tells the structure is auto-regressive AR(1). 
The RANDOM statement defines the random effects. In MB3 only intercept (β0i = γ00 + 
η0i) is varying. The output covParms table shows the estimate. The TYPE option tells the 
variance-covariance matrix of the random effects is unstructured and output asycov table 
shows the covariance matrix of the estimates. Now SAS data sets w1,w2,w3 and w4 are 
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generated by PROC MIXED procedure according to the ODS TRACE and OUTPUT. 
















Figure 3: SAS code for MB3, part 3: Matrix operation by Proc IML. 
The part 3 of the code is to use the corresponding SAS output data sets to set up 
the fixed effects and random effect and their covariance matrices and calculate the effect 
size.  PROC IML package in SAS can perform general matrix operation such as 
PROC IML; 
 P={0,1,0,7};   
 USE w3; READ all INTO Gamma;   
 USE w4; READ all INTO C_Gamma; 
  
 R={1,0,1}; 
 USE w1; READ all INTO Omiga; 
 USE w2; READ all INTO C_Omiga; 
 
 Trt7= T(P)*Gamma; Std_Trt= sqrt(T(P)*C_Gamma*P); 
 
 Tot_Var= T(R)* Omiga; 
 Std_Var=sqrt(T(R)*C_Omiga*R); 
 
 Delta_AB=T(P)*Gamma/sqrt(T(R)* Omiga); 
 







 PRINT p,Gamma,C_Gamma,R,Omiga,C_Omiga;  







multiplication, division, square root, etc. P and R vector can be named directly. The 
combination of USE and READ commands can set up matrices using the data sets 
produced in the PROC MIXED part. The constant k and degree of freedom v, effect size 
 ̂  , adjusted effect size gAB and variance of gAB are then calculated by PROC IML 
package according to the definitions from equation (10) to equation (15).  




SAS (W.X)  
Estimate (s.e.) 
Variance components     
  Autocorrelation (̂ ) 0.81 (0.02) 0.81 (0.09) 
  Within-case var. ( 2̂ ) 99.00 (6.20) 99.01 (44.74) 
  Between-case var. (
2
0̂ ) 14.77 (27.16) 14.75 (39.51) 
  Total variance (
2 2
0̂
ˆ  ) 113.77 (27.14)  113.76 (29.99) 
     
Fixed effects     
   Intercept ( 00̂ ) 52.93 (4.42) 52.93 (4.42) 
   Treatment ( 10̂ ) -1.37 (1.97) -1.37 (1.97) 
   Weekly trend ( 20̂ ) 0.49 (0.62) 0.49 (0.62) 
   Trt. × Trend ( 30̂ ) -1.90 (0.94) -1.90 (0.94) 
   Trt. effect after 7 weeks ( ˆTp γ ) -14.65 (6.34) -14.65 (6.34) 
     
Effect size     
   Unadjusted ( ˆAB ) -1.37   -1.37  
   Adjusted (gAB) -1.34 (0.63) -1.34 (0.63) 
   Degrees of freedom (ν) 35.15  28.77  
   Constant κ 0.59  0.59  
     
Log-likelihood -435.1  -435.1  
Akaike Info. Criterion 884.2  876.2  
 
The full SAS code is given in the APPENDIX section. In summary, the various datasets 
from the output of PROC MIXED in SAS can be converted to matrices easily and the 
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matrix operations in the package are straightforward. The sample calculation with all 
matrix elements is demonstrated  in MB4 section since MB4 has more complicated 
variance-covariance matrix for random effects. Table 1 shows the estimated results by 
MB3 from R and SAS side by side. 
The results from SAS and R are very close.  The fixed effects, unadjusted or 
adjusted effect size and Log-likelihood are nearly identical. The coefficients for variance 
components are the same,  but the standard deviations of the coefficients have variations 
which may result from the different algorithms for estimating the covariance matrix of 
variance components in SAS and R. Previous investigation has showed that MB3 is a 
poor fit to the data.  
MB4 Code and Results 
Model 4 has varying intercept, fixed treatment effect, varying trends and fixed 
interaction as in equation (5): 






Figure 4: SAS code for MB4, PROC MIXED part 
The code for MB4 in Figure 4 is almost identical as MB3 except for the 
RANDOM statement. In MB4 the baseline time trend is allowed to vary randomly across 
PROC MIXED data=schutte method=REML noclprint asycov covtest; 
CLASS case; 
MODEL Fatigue = Trt Week Trt_Week /solution covb; 
REPEATED /sub=case type = ar(1); 
RANDOM intercept Week / sub= case type=un; 
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cases besides the variation of the intercept. In the SAS code I add Week to the RANDOM 
command line.  
The RANDOM line in MB3 is: 
 
 
And the RANDOM line in MB4 is: 
 
 
 The full SAS code with explanation is attached in the Appendix section. 
The results from R and SAS are again very close for MB4, as listed in Table 2. 
Previous study has suggested MB4 has improved fit than MB3.  
Some examples of matrix operation are listed here. For the given choice of A, B 








Fixed effects   is from the Estimate of the SolutionF table from SAS output. 
SolutionF table describes the fixed effects solution vector. 
 
   (
   
   
   
   
)  (
     
     
    
     
), 
The covariance matrix of the fixed effects C( ) is from the CovB table from SAS 
output. CovB table describes the covariance matrix of fixed-effects parameter estimates. 
  
 
RANDOM intercept / sub= case type=un; 
 
RANDOM intercept Week / sub= case type=un; 
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random effects   is from the estimate of the CovParm table from SAS output. 



















         
         
         
         




                                           
 
 The covariance matrix of the random effects C( )is from the Asycov table from 
SAS output.  Asycov table describes asymptotic covariance matrix of covariance 
parameters.   
                                                
  






                                                  
                                                 
                                                  
                                                 






   
Trt. Effect after 7 weeks = P
T
 x γ =  -11.96606 ;  
Standard Deviation(s.e) of the Trt. effect after 7 weeks 
 =√     ( )   = 4.6086912; 
Total variance = r
T
x   =  125.10717 
s.e.of the Total variance = √     ( )     =   46.254256 
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√   
 = -1.069819 
            √
   ( ̂) 
   ̂
 = 0.4120373 
                    
 (   ̂) 
   ( ̂) 
 = 14.631572 
 ( )      (    ) = 0.9478499 
                          ( )   ̂   =    -1.014027                                                             
The variance of     is approximately  
   (   )   ( )
  
   
   
  ̂  
 (
 
   
 
 
 ( ) 
)  = 0.2232259 
And the s.e of the adjusted effect size     = 0.4724678 
Some estimates are interpreted as follows. First, 10̂  = -0.54, meaning that fatigue 
is immediately lowered by 0.54 point after application of the treatment. With 30̂ = -1.63, 
fatigue will be lowered by additional 1.63 points per week after the treatment. Together, 
fatigue will be lowered by 11.97 points seven weeks after treatment. Since 20̂ = 0.20, the 
average baseline trend is 0.20, which is close to zero. The variation of the baseline trend 
across cases (
2
2̂ ) is 1.99.  Total variance is 125.11 and the majority is coming from the 
between-case variance which is 95.71. Within-case variation is 29.39,  assumed to be 
constant for all cases. The unadjusted effect size is -1.07 of standard deviation unit and 
adjusted effect size is -1.01 of standard deviation unit with approximate variance 0.47. 
The average treatment effect is to lower the fatigue by 1 unit of standard deviation. Since 
the effect size is design-comparable it can be compared to that of other experiment 
designs or models.  
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Table 2. Model MB4 estimates for Schutte data by R and SAS 
Parameter 
R (J.P)  
Estimate (s.e.) 
SAS (W.X)  
Estimate (s.e.) 
Variance components     
  Autocorrelation (̂ ) 0.40 (0.09) 0.40 (0.13) 
  Within-case var. ( 2̂ ) 29.39 (4.16) 29.39 (6.55) 
  Between-case var. (
2
0̂ ) 95.71 (46.79) 95.71 (46.49) 
  Case-trend covariance (
20̂ ) 11.21 (6.36) 11.21 (6.37) 
  Trend variance (
2
2̂ ) 1.99 (1.07) 1.99 (1.08) 
  Total variance (
2 2
0̂
ˆ  ) 125.11 (46.76) 125.11 (46.25) 
     
Fixed effects     
   Intercept ( 00̂ ) 50.29 (4.07) 50.29 (4.07) 
   Treatment ( 10̂ ) -0.54 (1.75) -0.54 (1.75) 
   Weekly trend ( 20̂ ) 0.20 (0.62) 0.20 (0.62) 
   Trt. × Trend ( 30̂ ) -1.63 (0.66) -1.63 (0.65) 
   Trt. effect after 7 weeks ( ˆTp γ ) -11.97 (4.61) -11.97 (4.61) 
     
Effect size     
   Unadjusted ( ˆAB ) -1.07  -1.07  
   Adjusted (gAB) -1.01 (0.47) -1.01 (0.47) 
   Degrees of freedom (ν) 14.32  14.63  
   Constant κ 0.41  0.41  
     
Log-likelihood -429.0  -429  




MB5 Code and Results 
Model 5 has varying intercept, fixed treatment effect, varying trends and varying 
interaction as in equation (8): 
β0i = γ00 + η0i, β1i = γ10, β2i = γ20 + η2i, β3i = γ30 + η3i, 
By following the codes in MB3 and MB4, we can just change the RANDOM 
statement by adding a Trt_Week interaction term to the random effect as following: 
 
 
Instead of output similar results as in MB3 and MB4, an error message is received, 
stating that the iteration does not converge. In this model we have three random effects 
which means there are six terms in the covariance matrix. With only 12 cases in the 
dataset the REML method will be limited. The convergence problem is solved by 
changing the covariance matrix type from UN to UNR. The new random statement is: 
 
 
The MIXED documentation in SAS (12) describes the difference between 
TYPE=UN and TYPE=UNR covariance structures. When TYPE=UN, the variances are 
nonnegative, and the covariances are unstructured. On the other hand when TYPE=UNR,  
the structure fits the same model as the TYPE=UN option but with a different 
parameterization. The non-diagonal elements are correlations between the corresponding 
measurements instead of covariance and the absolute value of the correlation is 
constrained to be not greater than 1. We can change the TYPE option to UN for both 
RANDOM intercept Week Trt_Week/ sub= case type=un; 
RANDOM intercept Week Trt_Week/ sub= case type=unr; 
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MB3 and MB4 to achieve same estimation results if the nonnegative, unconstrained 
covariance structure is not sought. The results for MB5 with covariance type=UNR are 
listed in Table 3. 






Variance components     
  Autocorrelation (̂ ) 0.24 (0.11) 0.24 (0.12) 
  Within-case var. ( 2̂ ) 22.54 (3.35) 22.64 (3.93) 
  Between-case var. (
2
0̂ ) 38.30 (33.00) 75.71 (76.77) 
  Case-trend covariance ( 20̂ ) 0.38 (3.40) 0.93 (0.97) 
  Trend variance (
2
2̂ ) 0.15 (0.54) 0.16 (0.27) 
  Case-Trt. × Trend cov. ( 30̂ ) 1.74 (7.42) -0.17 (0.55) 
  Trend-Trt. × Trend cov. ( 32̂ ) 0.67 (0.96) 1 (0) 
  Trt. × Trend variance ( 3
2̂ ) 3.01 (2.70) 2.84 (2.11) 
  Total variance (
2 2
0̂
ˆ  ) 60.84 (32.74) 98.35 (77.50) 
     
Fixed effects     
   Intercept ( 00̂ ) 50.53 (2.82) 50.57 (3.39) 
   Treatment ( 10̂ ) 0.03 (1.60) 0.07 (1.61) 
   Weekly trend ( 20̂ ) 0.22 (0.36) 0.23 (0.38) 
   Trt. × Trend ( 30̂ ) -1.67 (0.74) -1.77 (0.73) 
   Trt. effect after 7 weeks ( ˆTp γ ) -11.67 (5.18) -12.33 (5.17) 
     
Effect size     
   Unadjusted ( ˆAB ) -1.50  -1.24  
   Adjusted (gAB) -1.33 (0.83) -0.93 (1.06) 
   Degrees of freedom (ν) 6.90  3.22  
   Constant κ 0.66  0.52  
     
Log-likelihood -424.5  -424.5  
Akaike Info. Criterion 873.0  863.0  
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 Although the estimated fixed effects by two codes are similar to each other and to 
MB4, the estimated variance components and effect size are quite different for MB5. The 
between-case variance in MB5 is 38.3 by R but 75.71 by SAS while it is 95.71 in MB4 
and 99 in MB3 by both codes.  Hence the total variance and standard deviation of the 
total variance are quite different, which also lead to larger effect size and adjusted effect 
size. The reduction of between-case variance from MB3 to MB4 or from MB4 to MB5 is 
because the introduction of the variance of trend or interaction so that the remaining 
unexplained variance is decreased. The difference of  between-case variation between R 
and SAS may be a result of  the different algorithms of restricted maximum likelihood 
estimation of variance-covariance components. For the three models with 12 cases, 
relaxed restriction on the boundary condition for variance-covariance matrix is necessary 




Effect size is very useful in studies evaluating the causal effect of intervention in 
social science, psychology and clinical study. Pustejovsky’s method to derive and 
estimate design-comparable effect size for treatment effects in multiple baselines is 
studied in this report. A successful estimation of effect size involves model selection, 
effect size construction and estimation. Three models with same fixed effects but 
different random effects are implemented by SAS PROC MIXED function with REML 
estimation. The Unadjusted effect size and adjusted effect size are then calculated by 
SAS matrix operation package PROC IML. The output and results from SAS are 
comparable to those by R for fixed effects in all models. The covariance estimation 
sometimes show different results at the boundary condition, which may be caused by 
different REML algorithm.  
Future studies may be conducted by evaluating the proposed effect size estimation 
by other software packages such as SPSS and HLM. One could monitor the capacity of 
convergence at extreme boundary conditions to explore different restricted maximum 
likelihood estimation algorithm and evaluate fitting data. One could also study more 
complicated data structure with more data hierarchy to generalize the proposed 
estimation and widen the application. One may also study different estimation methods 
other than REML such as Bayes’ estimator or MCMC algorithm. With the introduction of 
estimation of the design-comparable effect size for multiple baseline designs, more  








1. SAS code for MB4 with comment line 
OPTIONS formdlim='_' ls=100; 
 
FILENAME io 'U:\My Documents\My SAS Files\9.2\Effect_Size'; 




 INFILE io(Schutte.csv) dlm='2C0D'x dsd missover lrecl=10000 firstobs=2; 
 INPUT Num case Week Fatigue Trt CaseID Treatment$ Constant Trt_Week; 
/*print out a sample observations to make sure the file is read correctly*/ 
PROC PRINT DATA=schutte (obs=15); RUN;   
/*ODS trace on and off pair helps to track the table names from the output in 
the log file of SAS*/ 
/*ODS output will allow the direct reference and modification of the output 
tables and assigned to new dataset.*/ 
/*The keep and drop option is to modify the dataset for further usage*/ 
ODS TRACE ON; 
 ODS OUTPUT   
  CovParms=w1 (keep=covparm estimate)/*CovParms is table of 
estimation of the random parameters used for Omiga*/ 
  asycov=w2 (drop=row) /*asycov is the table of covariance matrix 
for random parameters used for C_Omiga*/  
  SolutionF=w3 (keep= effect estimate)/*SolutionnF is the table of 
estimation of fixed effects used for Gamma*/ 
  covb=w4 (drop =row); /*covb is the table of covariance matrix for 
fixed effects used for C_Gamma*/ 
/* Proc Mixed is to specify the regression model. */ 
/*The fixed effects are in the Model line, The random effects are in the random 
line*, the within-case variance is in repeated line*/  
PROC mixed DATA=schutte METHOD=REML noclprint asycov covtest; 
 CLASS case; 
 MODEL Fatigue = Trt Week Trt_Week /SOLUTION covb; 
 REPEATED /SUB=case TYPE = ar(1); 
 RANDOM intercept Week / SUB= case TYPE=un; 
 
RUN; 
ODS TRACE OFF; 
 
/*print out the dataset for matrix reference*/ 
PROC PRINT DATA=w1; 
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PROC PRINT DATA=w2; 
PROC PRINT DATA=w3; 
PROC PRINT DATA=w4; 
RUN; 
 
/* PROC IML is the package in SAS for matrix operation*/ 
PROC IML; 
 P={0,1,0,7}; /*define P vector as of day 7 after trearment*/ 
 USE w3; READ all INTO Gamma; /*define matrix of fixed effects as Gamma*/ 
 USE w4; READ all INTO C_Gamma; /* define matrix of covariance of fixed 
effects as C-Gamma*/ 
 
 R={1,0,0,0,1}; /*define r vector*/ 
 USE w1; READ all INTO Omiga; /*define the matrix of random effects as 
Omiga*/ 
 USE w2; READ all INTO C_Omiga; /*define the matrix of covariance of 
random effects as C_Omiga*/ 
 
 Trt7= T(P)*Gamma; Std_Trt= sqrt(T(P)*C_Gamma*P);/*estimate the treatment 
effect and standard deviation after 7 weeks*/ 
 Tot_Var= T(R)* Omiga; /*estimate total variance*/ 
 Std_Var=sqrt(T(R)*C_Omiga*R); /*estimate the standard deviation of the 
total variance*/ 
 Delta_AB=T(P)*Gamma/sqrt(T(R)* Omiga); /*estimate the unadjusted effect 
size*/ 
 k=sqrt((T(P)*C_Gamma*P)/(T(R)* Omiga)); /*estimate constant k*/ 
 v=2*((T(R)*Omiga)**2)/(T(R)*C_Omiga*R); /*estimate degree of freedom v*/ 
 j_v=1-3/(4*v-1); /*estimate j*/ 
 G_AB=j_v*Delta_AB; /*estimate the adjusted effect size*/ 
 V_G_AB=j_v**2*(v*(k**2)/(v-2)+(Delta_AB**2)*(v/(v-2)-1/(j_v**2))); 
/*estimate the variance of adjusted effect size*/ 
 Std_Vgab=sqrt(V_G_AB); /*estimate the standard deviation of effect size*/ 
 
 PRINT p,Gamma,C_Gamma,R,Omiga,C_Omiga;  
 PRINT Tot_Var, Std_Var,Trt7,Std_Trt,Delta_AB,k,v, j_v, 
G_AB,V_G_AB,Std_Vgab; 
  
QUIT; /*Quit from PROC IML*/ 
RUN; 
 
The only difference for MB3 and MB5 to MB4 is the RANDOM line in PROC MIXED and 
R matrix in PROC IML: 
 
SAS code for MB3: 
 
RANDOM intercept / SUB= case TYPE=un; 
R={1,0,1}; 
 
SAS code for MB5: 
 






2. PROC MIXED Options Summary 
The following summarize most options in PROC MIXED Statement.  
DATA=  Specifies input data set 
METHOD=  Specifies the estimation method 
ASYCOV  Displays asymptotic covariance matrix of covariance parameter estimates 
NOCLPRINT Suppresses “Class level information” completely or in parts 
COVTEST  Produces asymptotic standard errors for the covariance parameter 
estimates 
MODEL Name the single dependent variable and fixed effects 
SOLUTION Displays the fixed-effects parameter estimates 
COVB  Displays the covariance matrix of the fixed-effects parameter estimates 
REPEATED Specify the R
1
 matrix in mixed model 
RANDOM  Defines the random-effects and G
2
 matrix in mixed model 
TYPE  Specify the covariance structure 
1
 R matrix: the variance-covariance matrix for random residuals, can be viewed as within-subject variance-
covariance matrix 
2
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